Phase 1 Study of Medtronic Closed Loop Device With ePID Algorithm and Enlite Sensors on Adjuvant Therapy With Insulin and Liraglutide to Minimize Post-prandial Hyperglycemia
Phase of Trial: Phase I
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Liraglutide (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 22 Jun 2015 Status change from recruiting to completed, as per ClinicalTrials.gov record.
- 09 Jun 2015 End point (to achieve better post-prandial glycemic measures while the subject is on the Medtronic closed loop device) met as per abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.